NCT07403201RecruitingEarly phase 1
The Effect of Therapy Combination in PCOS With Dlbs 3233
The Effect of Combination Therapy Dlbs 3233 and Clomifen Citrate vs Clomifen Citrate on Homa ir, Maturation Follicle, and Menstrual Cycle in PCOS Cases at Muhammadiyah Asri Medical Center Hospital
Source: ClinicalTrials.gov · Last updated 11 Feb 2026
Brief summary (registry, in English)
The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital
- Status (registry)
- Recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- First submitted
- 24 Nov 2021
- Start date
- 15 Dec 2021
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Inlacinpenelitian
- NCT number
- NCT07403201
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 90
- From 15 Dec 2021 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- dis agree to join research
Who the study is looking for
- married agree to join this research
Age in the registry: - to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| RS AMC Yogyakarta Coordinator of this site? Confirm its status | Yogyakarta | Indonesia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.